Heroin addicts face barriers to treatment

Published April 22, 2014

Heroin addicts face barriers to treatment
In the course of Marchese's five-year battle with heroin, the Blackwood, N.J., man was repeatedly denied admission to treatment facilities, often because his insurance company wouldn't cover the cost. Then one night in June 2010, a strung-out Marchese …
Read more on Knoxville News Sentinel

Novartis reshapes business with GSK, Lilly deals
Two GSK cancer drugs, Tafinlar and Mekinist, would give Novartis a strong position for melanoma treatments. Tykerb, for metastatic breast cancer, and Arzerra, for chronic lymphocytic leukemia for thrombocytopenia, are two other drugs included in the deal.
Read more on Knoxville News Sentinel

More Drug Treatment Centers Knoxville Information…